I'll be going to this meeting, I found the titles most interesting. I also found the participant list interesting.http://cme.med.harvard.edu/index.asp?SECTION=CLASSES&ID=00271222Dr Mike Picard will be a presenter and... look down to the end of Monday's schedule... there will be case studies in echo (woo hoo for me). The last two meetings of the day are under this heading..CONTRAST ECHO FOR PERFUSION: CONVINCE US!the last meeting of the day is titled...CASE STUDIES: Perfusion imaging with echo contrast- Ready for Prime-Time - Michael H. Picard, MD, Paul A. Grayburn, MD, Marielle Scherrer-Crosbie, MDit won't be ACUS controlling the presentations here. I'll look forward to it and will commit to a final "How I spent my sumer vacation" report for the board as we go into the approval process.Why hold ACUS now? I personally think it's at trough right now. I'll bet a 50% RETURN moving into the accouncement of NDA submisson. But I'll tell you right now that if I don't like what I hear in Oct, I'll tell it, wait two weeks, and be largely done with ACUS. This meeting will be my personal final decision point :) good luck to all
Best Of |
Favorites & Replies |
Start a New Board |
My Fool |
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ra